Is the Maestro actually available for purchase?

Not available to consumers. In internal use by Moon Surgical. Source: https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro.

Where is the Maestro being used?

No verified field deployments on record.

No incidents on record, but with no verified field deployments either, the absence is uninformative.

Who makes the Maestro?

Maestro is made by Moon Surgical, based in San Carlos, California, USA. Source: https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro.

Consumer model

Maestro

By Moon Surgical · surgical

Price: —
Availability: Internal use only (not for retail).
Maturity: commercial
Real-world use: No verified deployments

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

Readiness

Maestro is internal use only (not for retail), no capability claims are on file, the model has no verified field deployments in the registry, and no incidents are on record.

Availability

internal-only

Internal use only (not for retail).

see evidence →

Price honesty

no-price

No price points on file for Maestro.

see evidence →

Capability honesty

no-claims

No reviewed capability claims on file for Maestro.

see evidence →

Real-world use

commercial

Maturity: commercial. No verified deployments in the registry.

see evidence →

Safety record

no-incidents

No incidents on record. No verified deployments either.

What it claims to do

No reviewed capability claims on file.

Price

No reviewed price points on file.

Real-world use

No verified deployments on file for Maestro.

Safety record

No incidents on record. No verified deployments either, so the absence is uninformative.

Privacy

No privacy practices disclosed or on file for Maestro.

Specs

notes: [{"label":"Verified","value":"Moon Surgical (private; Paris + San Carlos CA; CEO Anne Osdoit; board chair Fred Moll, Intuitive co-founder; backers Sofinnova + NVentures/NVIDIA) makes Maestro, a laparoscopic surgical-ASSISTANT/collaboration robot (holds/positions instruments alongside the surgeon, not a full teleop console). Commercial Maestro FDA 510(k)-cleared Jun 5 2024 (K240598); >1,100 patients treated across US + Europe (company-stated). ~$90M+ raised."},{"label":"AI-substance: genuine SHIPPED AI (notable)","value":"ScoPilot is a genuine SHIPPED, FDA-cleared AI feature (intraoperative scope control via NVIDIA Holoscan), with a PCCP - not merely demonstrated. This distinguishes Maestro from the teleop-only platforms in this cohort. Maestro itself is a collaborative/assist robot (an honest distinction from full master-slave teleop)."},{"label":"CORRECTION (pathway)","value":"Maestro went the 510(k) route (K240598), NOT de novo (the dispatch hypothesized de novo). De novo around that time was Virtual Incision/MIRA and MMI/Symani - different companies."},{"label":"Claimed but NOT verified","value":"CE mark status/date (unverified this pass); exact installed-system count; the 'industry's first AI on a commercial surgical robot' superlative (marketing); the >1,100-patients figure (company-sourced)."}]
products: Maestro: a laparoscopic surgical-assistant platform (holds/positions instruments + endoscope alongside the surgeon). ScoPilot: shipped AI software (NVIDIA Holoscan-powered) for intraoperative scope control. Commercial Maestro FDA 510(k) K240598 cleared Jun 5 2024; ScoPilot FDA-cleared 2025 with a Predetermined Change Control Plan (PCCP).
formFactor: surgical (laparoscopic surgical-assistant / collaboration robot: holds + positions instruments alongside the surgeon; not full master-slave teleop)

What's under the hood

No brain on file for Maestro.

Frequently asked questions

Is the Maestro actually available for purchase?: Not available to consumers. In internal use by Moon Surgical.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)
What does the Maestro cost?: Not announced.
Where is the Maestro being used?: No verified field deployments on record.
Is the Maestro safe?: No incidents on record, but with no verified field deployments either, the absence is uninformative.
How does the Maestro handle privacy?: No privacy practices disclosed or on file for Maestro.
Who makes the Maestro?: Maestro is made by Moon Surgical, based in San Carlos, California, USA.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)

Manufacturer

Moon Surgical (registry record: /companies/moon-surgical)

Compared to

Hugo RASby Medtronic · surgical

Sources

Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024) · https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro
FDA 510(k) K240598: Maestro System (cleared Jun 5 2024) · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K240598
Moon Surgical ScoPilot AI FDA clearance (with PCCP; NVIDIA Holoscan) · https://www.biospace.com/moon-surgical-scopilot-fda-nvidia-holoscan
Moon Surgical raises $55.4M; Fred Moll board chair; NVentures-backed · https://www.massdevice.com/moon-surgical-funding-fred-moll/

Machine-readable: this page as markdown.

Canonical: https://deploy.report/models/moon-maestro